• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像综合视觉评定量表:在阿尔茨海默病前驱期的应用

Comprehensive Visual Rating Scale on Magnetic Resonance Imaging: Application to Prodromal Alzheimer Disease.

作者信息

Chung Jae Kyung, Jang Jae-Won

机构信息

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea.

Department of Neurology, Kangwon National University College of Medicine, Chuncheon, Korea.

出版信息

Ann Geriatr Med Res. 2021 Mar;25(1):39-44. doi: 10.4235/agmr.21.0010. Epub 2021 Mar 15.

DOI:10.4235/agmr.21.0010
PMID:33715339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8024168/
Abstract

BACKGROUND

A comprehensive visual rating scale (CVRS) using brain magnetic resonance imaging (MRI) was previously developed to evaluate structural changes in the brains of older patients. This study investigated the usefulness of the CVRS in predicting dementia with Alzheimer disease (AD) in patients with prodromal AD.

METHODS

We included 189 patients with prodromal AD with available data from the Alzheimer's Disease Neuroimaging Initiative study. We evaluated all patients using CVRS and assessed their progression to AD dementia over 3 years of longitudinal follow-up. Survival analysis was performed using the Cox proportional hazards model to analyze the hazard ratios of the CVRS for progression to AD dementia.

RESULTS

Among 189 patients with prodromal AD, 61 (32.3%) progressed to dementia. The mean baseline CVRS scores differed significantly between the stable and progressive groups (9.9±5.1 vs. 12.4±4.9; p=0.002). An initial high CVRS score was an independent risk factor for the progression to AD dementia (hazard ratio=1.110; 95% confidence interval, 1.043-1.182).

CONCLUSION

The baseline CVRS score predicted the progression to dementia in patients with prodromal AD, indicating its independent association with longitudinal cognitive decline.

摘要

背景

先前已开发出一种使用脑磁共振成像(MRI)的综合视觉评分量表(CVRS),用于评估老年患者大脑的结构变化。本研究调查了CVRS在预测前驱期阿尔茨海默病(AD)患者发生AD痴呆方面的有效性。

方法

我们纳入了189例来自阿尔茨海默病神经影像学倡议研究且有可用数据的前驱期AD患者。我们使用CVRS对所有患者进行评估,并在3年的纵向随访中评估他们向AD痴呆的进展情况。使用Cox比例风险模型进行生存分析,以分析CVRS对进展为AD痴呆的风险比。

结果

在189例前驱期AD患者中,61例(32.3%)进展为痴呆。稳定组和进展组的平均基线CVRS评分存在显著差异(9.9±5.1对12.4±4.9;p=0.002)。初始CVRS高分是进展为AD痴呆的独立危险因素(风险比=1.110;95%置信区间,1.043 - 1.182)。

结论

基线CVRS评分可预测前驱期AD患者向痴呆的进展,表明其与纵向认知衰退存在独立关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/491b/8024168/7d82f1db0225/agmr-21-0010f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/491b/8024168/7d82f1db0225/agmr-21-0010f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/491b/8024168/7d82f1db0225/agmr-21-0010f1.jpg

相似文献

1
Comprehensive Visual Rating Scale on Magnetic Resonance Imaging: Application to Prodromal Alzheimer Disease.磁共振成像综合视觉评定量表:在阿尔茨海默病前驱期的应用
Ann Geriatr Med Res. 2021 Mar;25(1):39-44. doi: 10.4235/agmr.21.0010. Epub 2021 Mar 15.
2
A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.用于预测轻度认知障碍患者向痴呆进展的“综合视觉评分量表”。
PLoS One. 2018 Aug 20;13(8):e0201852. doi: 10.1371/journal.pone.0201852. eCollection 2018.
3
A Comprehensive Visual Rating Scale for Predicting Progression from Mild Cognitive Impairment to Dementia in Patients with Alzheimer's Pathology or Suspected Non-Alzheimer's Pathology.一种用于预测阿尔茨海默病病理或疑似非阿尔茨海默病病理患者从轻度认知障碍进展为痴呆的综合视觉评定量表。
Dement Neurocogn Disord. 2020 Dec;19(4):129-139. doi: 10.12779/dnd.2020.19.4.129.
4
A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.脑磁共振成像的综合视觉评分量表:在患有阿尔茨海默病、轻度认知障碍和认知正常的老年受试者中的应用。
J Alzheimers Dis. 2015;44(3):1023-34. doi: 10.3233/JAD-142088.
5
Predicting progression to dementia with "comprehensive visual rating scale" and machine learning algorithms.使用“综合视觉评定量表”和机器学习算法预测痴呆症进展
Front Neurol. 2022 Aug 22;13:906257. doi: 10.3389/fneur.2022.906257. eCollection 2022.
6
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.认知和神经影像学特征以及阿尔茨海默病风险个体的脑β-淀粉样蛋白(INSIGHT-preAD):一项纵向观察性研究。
Lancet Neurol. 2018 Apr;17(4):335-346. doi: 10.1016/S1474-4422(18)30029-2. Epub 2018 Feb 27.
7
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.阿尔茨海默病病理和进展的脑和血液代谢物特征:靶向代谢组学研究。
PLoS Med. 2018 Jan 25;15(1):e1002482. doi: 10.1371/journal.pmed.1002482. eCollection 2018 Jan.
8
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.认知健康的老年疑似非阿尔茨海默病病理生理学 (SNAP) 或阿尔茨海默病病理个体的临床和认知轨迹:一项纵向研究。
Lancet Neurol. 2016 Sep;15(10):1044-53. doi: 10.1016/S1474-4422(16)30125-9. Epub 2016 Jul 20.
9
Prevalence and prognosis of prodromal Alzheimer's disease as assessed by magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography in a community: reanalysis from the Osaki-Tajiri Project.通过磁共振成像和18F-氟脱氧葡萄糖-正电子发射断层扫描评估社区前驱性阿尔茨海默病的患病率和预后:来自大崎-田尻项目的重新分析
Psychogeriatrics. 2016 Mar;16(2):116-20. doi: 10.1111/psyg.12131. Epub 2015 Jun 26.
10
Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.路易体前驱性痴呆与阿尔茨海默病前驱期:认知和临床特征比较
J Alzheimers Dis. 2017;58(2):463-470. doi: 10.3233/JAD-161089.

引用本文的文献

1
Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy.假性剥脱症与阿尔茨海默病相关脑萎缩的关系。
PLoS One. 2023 Jun 8;18(6):e0286727. doi: 10.1371/journal.pone.0286727. eCollection 2023.

本文引用的文献

1
Alzheimer's Disease Clinical Trials: Moving Toward Successful Prevention.阿尔茨海默病临床试验:迈向成功的预防。
CNS Drugs. 2019 Feb;33(2):99-106. doi: 10.1007/s40263-018-0598-1.
2
A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.用于预测轻度认知障碍患者向痴呆进展的“综合视觉评分量表”。
PLoS One. 2018 Aug 20;13(8):e0201852. doi: 10.1371/journal.pone.0201852. eCollection 2018.
3
Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.
磁共振成像在阿尔茨海默病和轻度认知障碍中的应用。
J Neurol. 2019 Jun;266(6):1293-1302. doi: 10.1007/s00415-018-9016-3. Epub 2018 Aug 17.
4
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.阿尔茨海默病生物标志物日常实践(ABIDE)项目中个体轻度认知障碍患者生物标志物结果的解读
JAMA Neurol. 2017 Dec 1;74(12):1481-1491. doi: 10.1001/jamaneurol.2017.2712.
5
Impact of multiple pathologies on the threshold for clinically overt dementia.多种病变对临床显性痴呆阈值的影响。
Acta Neuropathol. 2017 Aug;134(2):171-186. doi: 10.1007/s00401-017-1717-7. Epub 2017 May 9.
6
Manual Planimetry of the Medial Temporal Lobe Versus Automated Volumetry of the Hippocampus in the Diagnosis of Alzheimer's Disease.内侧颞叶的手工平面测量法与海马体的自动容积测量法在阿尔茨海默病诊断中的应用
Cureus. 2016 Mar 26;8(3):e544. doi: 10.7759/cureus.544.
7
Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.使用视觉评分诊断痴呆症:对 MRI 萎缩量表的批判性评估。
J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1225-33. doi: 10.1136/jnnp-2014-310090. Epub 2015 Apr 14.
8
Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging.在梅奥诊所衰老研究中预测轻度认知障碍的风险。
Neurology. 2015 Apr 7;84(14):1433-42. doi: 10.1212/WNL.0000000000001437. Epub 2015 Mar 18.
9
A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.脑磁共振成像的综合视觉评分量表:在患有阿尔茨海默病、轻度认知障碍和认知正常的老年受试者中的应用。
J Alzheimers Dis. 2015;44(3):1023-34. doi: 10.3233/JAD-142088.
10
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.推进阿尔茨海默病研究诊断标准:IWG-2 标准。
Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0.